HIGHLIGHTS
- who: Top from the INSERM, CRCM, France have published the paper: A FcγRIII-engaging bispecific antibody expands the range of, in the Journal: (JOURNAL)
- what: The authors report the design of a Fab-like bispecific antibody (HER2bsFab) that displays a moderate affinity for and a unique specific and high affinity for FcγRIII.
- how: In an attempt to explain why HER2bsFab had no anti-proliferative effect the authors analyzed the impact of HER2bsFab on the activation of downstream MAPK and PI3K/AKT signaling pathways as these molecular events reflect HER2 activity (Fig . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.